We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Risk of Preelcampsia Linked to Body Fat

By HospiMedica staff writers
Posted on 27 Apr 2004
A new study of pregnant women has found that the risk of preeclampsia rises sharply with an increase in pre-pregnancy body fat. More...
The finding was presented at the annual meeting of the American Society for Nutritional Sciences in Washington, DC (USA), in April 2004.

The study, involving 1,179 pregnant women, found that the risk of preeclampsia rose sharply with even relatively small increases in pre-pregnancy body fat. What was most surprising was that the risk was elevated even among women who would not normally be classified as overweight when compared to women with less body fat. The study was presented by Lisa Bodnar, Ph.D., M.P.H., R.D., a postdoctoral fellow at the Magee-Womens Research Institute (Pittsburgh, PA, USA), affiliated with the University of Pittsburgh (PA, USA).

Compared to women with a normal pre-pregnancy body mass index (BMI) of 21 (130 pounds), women with a pre-pregnancy BMI of 26 (160 pounds), classified as "overweight” with a high ratio of body fat to muscle, were twice as likely to develop preeclampsia. Women with a BMI of 30 (185 pounds), classified as "obese,” were three times as likely to develop preeclampsia as the normal BMI women. The most surprising finding, according to Dr. Bodnar, was that a woman with a pre-pregnancy BMI of 17, classified as "underweight,” was only half as likely to develop preeclampsia as a woman with a BMI of 21, considered "normal weight.”

Further analysis of the data suggests that about half of the increased risk of preeclampsia is due to two factors long suspected of playing a role in its development. These are a heightened inflammatory response, often associated with high body mass, and elevated lipid values in the blood related to being overweight. Dr. Bodnar noted that understanding the mechanisms of the BMI/preeclampsia relationship could be extremely helpful in finding ways to treat the condition.


Related Links:
McGee Women's

Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Emergency Ventilator
Shangrila935
IV Therapy Cart
Avalo I.V Therapy Cart
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.